TrialJournal of medical virology2023

A Phase 2 open label study of ledipasvir/sofosbuvir for 12 weeks in subjects with hepatitis B virus infection.

Angie S Price et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.